WRBC
TLSI icon

W.R. Berkley Corp’s TriSalus Life Sciences TLSI Stock Holding History

W.R. Berkley Corp’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-102,476
Closed -$1.02M – 353
2022
Q3 		$1.02M Hold
102,476
– – 0.05% 337
2022
Q2 		$1.01M Buy
102,476
+49,999
+95% +$491K 0.05% 341
2022
Q1 		$514K Sell
52,477
-293,708
-85% -$2.9M 0.03% 446
2021
Q4 		$3.42M Hold
346,185
– – 0.19% 120
2021
Q3 		$3.44M Buy
+346,185
New +$3.39M 0.23% 89
2021
Q2 		– Sell
-24,846
Closed -$240K – 385
2021
Q1 		$240K Buy
+24,846
New +$252K 0.03% 280

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

W.R. Berkley Corp's TLSI Position: Q4 2022 in Review

W.R. Berkley Corp sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 102,476 shares — an estimated $1.02M sold.

W.R. Berkley Corp first reported a position in TLSI in Q1 2021 and held it in 6 quarters. The position peaked at $3.44M in Q3 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • W.R. Berkley Corp reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • W.R. Berkley Corp sold 102,476 TriSalus Life Sciences shares in Q4 2022, an estimated $1.02M.
  • W.R. Berkley Corp first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 6 quarters.
  • W.R. Berkley Corp's TriSalus Life Sciences position peaked at $3.44M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on W.R. Berkley Corp's 13F filing for Q4 2022, filed 14 Feb 2023.